Scarica l'app Stockscreener
3.73
5.81%
-0.23
Precedente Chiudi:
$3.96
Aprire:
$3.95
Volume 24 ore:
100.10K
Relative Volume:
0.03
Capitalizzazione di mercato:
$2.24M
Reddito:
$5.66M
Utile/perdita netta:
$-15.88M
Rapporto P/E:
-0.3297
EPS:
-11.3134
Flusso di cassa netto:
$-10.93M
1 W Prestazione:
-21.06%
1M Prestazione:
-30.28%
6M Prestazione:
-90.99%
1 anno Prestazione:
-92.71%
Intervallo 1D:
$3.60
$3.95
Intervallo di 1 settimana:
$3.23
$4.75
Portata 52W:
$3.23
$80.70
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, NTRA, A, IDXX
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
3.73 | 2.24M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
690.00 | 255.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
229.04 | 161.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
393.44 | 56.71B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.97 | 48.77B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
560.36 | 44.15B | 4.45B | 1.10B | 1.06B | 13.59 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
Form 424B5 bioAffinity Technologies Inc For: 10 October By Investing.com - Investing.com Canada
bioAffinity Technologies closes $4M stock offering on Nasdaq - StreetInsider
bioAffinity Technologies plans $4M stock offering on Nasdaq - StreetInsider
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - Business Wire
Japan intends to grant a patent for a home-collected lung cancer risk test - Stock Titan
More than 1,620 tests to assess lung cancer risk were delivered through Q3 2026. - Stock Titan
Shares could be offered up to 35% below market; bioAffinity Technologies (BIAF) seeks a stockholder vote. - Stock Titan
BIAF Historical Stock Prices & Daily Price Data | bioAffinity Technologies, Inc. Common - Quiver Quantitative
Form 8K bioAffinity Technologies Inc For: 22 September By Investing.com - Investing.com Nigeria
A 2,000-patient study is evaluating a lung cancer test using at-home samples. - Stock Titan
BIAF Stock Soars As Hong Kong Patent Ignites Trading - stockstotrade.com
BIAF Stock Jolts Higher On Nasdaq Win And Federal Deal - stockstotrade.com
bioAffinity Gets Hong Kong Patent for CyPath Lung Test | BIAF Stock News - Stock Titan
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com Canada
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com India
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com UK
BioAffinity Technologies (NASDAQ: BIAF) Announces Presentation Materials for 2026 H.C. Wainwright Global Investment Conference - Kalkine Media
Why Did bioAffinity (NASDAQ:BIAF) Regain Nasdaq Compliance? - Kalkine Media
bioAffinity Regains Nasdaq Compliance, Maintains Capital Market Listing - The Globe and Mail
bioAffinity Regains Nasdaq Compliance, Maintains Capital Market Listing - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
bioAffinity Technologies shares rise after Nasdaq compliance update - Quiver Quantitative
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
BIAF Stock Jumps As Federal Deal Fuels CyPath Lung Momentum - timothysykes.com
bioAffinity Technologies regains Nasdaq compliance after bid-price recovery - TradingView
BIAF Stock Pops As CyPath Lung Wins Federal Distribution - StocksToTrade
Congrats to the folks who joined at $10. Don't forget to give me a like 😘 - Moomoo
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Yahoo Finance UK
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Business Wire
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - FinancialContent
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
Top Small Cap Stocks To ConsiderSeptember 7th - MarketBeat
Small Cap Stocks To Follow NowSeptember 5th - MarketBeat
BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setup - stockstotrade.com
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance
bioAffinity Technologies to Present Corporate Update at Conference - The Globe and Mail
AOUT, NX, and BIAF stocks soar on strong earnin... - pluang.com
bioAffinity Technologies Inc. Warrant (BIAFW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$15.5 to $19.35 🫡 - Moomoo
You know I'm drunk, so my words carry extra weight 😘 - Moomoo
bioAffinity Technologies to Present Corporate Update at Conference - TipRanks
bioAffinity Technologies to Present Corporate Update at H.C. Wainwright Conference; Market Cap ~$5.9M - TradingView
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federa - The National Law Review
Biotech Stocks To Follow NowSeptember 3rd - MarketBeat
BIAF Stock Pops As Federal Lung Test Deal Fuels Momentum - timothysykes.com
BIAF Stock Jumps As Federal Deal Fuels Lung Test Growth - StocksToTrade
bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):